Cardiac amyloidosis is prevalent in older patients with aortic stenosis and carries worse prognosis

Journal of Cardiovascular Magnetic Resonance

Volumn 19, Issue 1, 2016, Pages

  Cavalcante, João L ^a,b   Rijal, Shasank ^a   Abdelkarim, Islam ^a   Althouse, Andrew D ^a   Sharbaugh, Michael S ^a   Fridman, Yaron ^a,b   Soman, Prem ^a   Forman, Daniel E ^a   Schindler, John T ^a   Gleason, Thomas G ^a   Lee, Joon S ^a   Schelbert, Erik B ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Aortic Stenosis; Cardiac Amyloidosis; Cardiovascular magnetic resonance; Outcomes

Indexed keywords

CONTRAST MEDIUM; GADOLINIUM; GADOTERIDOL; HETEROCYCLIC COMPOUND; ORGANOMETALLIC COMPOUND;

AGE; AGED; AMYLOIDOSIS; AORTIC VALVE STENOSIS; CARDIOMYOPATHY; CHI SQUARE DISTRIBUTION; COMORBIDITY; DIAGNOSTIC IMAGING; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART VALVE REPLACEMENT; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PENNSYLVANIA; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SEX FACTOR; TIME FACTOR; VERY ELDERLY;

AGE FACTORS; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; AORTIC VALVE STENOSIS; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; COMORBIDITY; CONTRAST MEDIA; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; GADOLINIUM; HEART VALVE PROSTHESIS IMPLANTATION; HETEROCYCLIC COMPOUNDS; HUMANS; KAPLAN-MEIER ESTIMATE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGANOMETALLIC COMPOUNDS; PENNSYLVANIA; PREVALENCE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS;

EID: 85051003998     PISSN: 10976647     EISSN: 1532429X     Source Type: Journal    
DOI: 10.1186/s12968-017-0415-x     Document Type: Article

References (36)

1. Tanskanen, M, Peuralinna, T, Polvikoski, T, Notkola, IL, Sulkava, R, Hardy, J, Singleton, A, Kiuru-Enari, S, Paetau, A, Tienari, PJ, Myllykangas, L, Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med 40 (2008), 232–239 PubMed PMID: 18382889 10.1080/07853890701842988.
2. Nietlispach, F, Webb, JG, Ye, J, Cheung, A, Lichtenstein, SV, Carere, RG, Gurvitch, R, Thompson, CR, Ostry, AJ, Matzke, L, Allard, MF, Pathology of transcatheter valve therapy. JACC Cardiovasc Interv 5 (2012), 582–590 PubMed PMID: 22625199 10.1016/j.jcin.2012.03.012.
3. Longhi, S, Lorenzini, M, Gagliardi, C, Milandri, A, Marzocchi, A, Marrozzini, C, Saia, F, Ortolani, P, Biagini, E, Guidalotti, PL, et al. Coexistence of degenerative aortic Stenosis and wild-type Transthyretin-related cardiac Amyloidosis. JACC Cardiovasc Imaging 9 (2016), 325–327 PubMed PMID: 26189123 10.1016/j.jcmg.2015.04.012.
4. Haloui, F, Salaun, E, Maysou, L, Dehaene, A, Habib, G, Cardiac amyloidosis: an unusual cause of low flow-low gradient aortic stenosis with preserved ejection fraction. Eur Heart J Cardiovasc Imaging, 17, 2016, 383 PubMed PMID: 26825321 10.1093/ehjci/jev342.
5. Sperry, BW, Jones, BM, Vranian, MN, Hanna, M, Jaber, WA, Recognizing Transthyretin cardiac Amyloidosis in patients with aortic Stenosis: impact on prognosis. JACC Cardiovasc Imaging 9:7 (2016), 904–906.
6. Galat, A, Guellich, A, Bodez, D, Slama, M, Dijos, M, Zeitoun, DM, Milleron, O, Attias, D, Dubois-Rande, JL, Mohty, D, et al. Aortic stenosis and transthyretin cardiac amyloidosis: the chicken or the egg?. Eur Heart J 37:47 (2016), 3525–3531.
7. Treibel TA, Fontana M, Gilbertson JA, Castelletti S, White SK, Scully PR, Roberts N, Hutt DF, Rowczenio DM, Whelan CJ, et al. Occult Transthyretin cardiac Amyloid in severe Calcific aortic Stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging. 2016;9(8).
8. Osnabrugge, RL, Mylotte, D, Head, SJ, Van Mieghem, NM, Nkomo, VT, LeReun, CM, Bogers, AJ, Piazza, N, Kappetein, AP, Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol 62 (2013), 1002–1012 PubMed PMID: 23727214 10.1016/j.jacc.2013.05.015.
9. Di Bella, G, Pizzino, F, Minutoli, F, Zito, C, Donato, R, Dattilo, G, Oreto, G, Baldari, S, Vita, G, Khandheria, BK, Carerj, S, The mosaic of the cardiac amyloidosis diagnosis: role of imaging in subtypes and stages of the disease. Eur Heart J Cardiovasc Imaging 15 (2014), 1307–1315 PubMed PMID: 25190073 10.1093/ehjci/jeu158.
10. Falk, RH, Quarta, CC, Dorbala, S, How to image cardiac amyloidosis. Circ Cardiovasc Imaging 7 (2014), 552–562 PubMed PMID: 24847009; PMCID 4118308 10.1161/CIRCIMAGING.113.001396.
11. Maceira, AM, Joshi, J, Prasad, SK, Moon, JC, Perugini, E, Harding, I, Sheppard, MN, Poole-Wilson, PA, Hawkins, PN, Pennell, DJ, Cardiovascular magnetic resonance in cardiac amyloidosis. Circulation 111 (2005), 186–193 PubMed PMID: 15630027 10.1161/01.CIR.0000152819.97857.9D.
12. Syed, IS, Glockner, JF, Feng, D, Araoz, PA, Martinez, MW, Edwards, WD, Gertz, MA, Dispenzieri, A, Oh, JK, Bellavia, D, et al. Role of cardiac magnetic resonance imaging in the detection of cardiac amyloidosis. JACC Cardiovasc Imaging 3 (2010), 155–164 PubMed PMID: 20159642 10.1016/j.jcmg.2009.09.023.
13. Austin, BA, Tang, WH, Rodriguez, ER, Tan, C, Flamm, SD, Taylor, DO, Starling, RC, Desai, MY, Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. JACC Cardiovasc Imaging 2 (2009), 1369–1377 PubMed PMID: 20083070 10.1016/j.jcmg.2009.08.008.
14. Fontana, M, Pica, S, Reant, P, Abdel-Gadir, A, Treibel, TA, Banypersad, SM, Maestrini, V, Barcella, W, Rosmini, S, Bulluck, H, et al. Prognostic value of late gadolinium enhancement cardiovascular magnetic resonance in cardiac Amyloidosis. Circulation 132 (2015), 1570–1579 PubMed PMID: 26362631; PMCID 4606985 10.1161/CIRCULATIONAHA.115.016567.
15. Maceira, AM, Prasad, SK, Hawkins, PN, Roughton, M, Pennell, DJ, Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis. J Cardiovasc Magn Reson, 10, 2008, 54 PubMed PMID: 19032744; PMCID 2605441 10.1186/1532-429X-10-54.
16. Lang, RM, Badano, LP, Mor-Avi, V, Afilalo, J, Armstrong, A, Ernande, L, Flachskampf, FA, Foster, E, Goldstein, SA, Kuznetsova, T, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (2015), 1–39 PubMed PMID: 25559473; e14 10.1016/j.echo.2014.10.003.
17. Nagueh, SF, Smiseth, OA, Appleton, CP, Byrd, BF 3rd, Dokainish, H, Edvardsen, T, Flachskampf, FA, Gillebert, TC, Klein, AL, Lancellotti, P, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 29 (2016), 277–314 PubMed PMID: 27037982 10.1016/j.echo.2016.01.011.
18. Baumgartner, H, Hung, J, Bermejo, J, Chambers, JB, Evangelista, A, Griffin, BP, Iung, B, Otto, CM, Pellikka, PA, Quinones, M, Eae/ASE: Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. Eur J Echocardiogr 10 (2009), 1–25 PubMed PMID: 19065003 10.1093/ejechocard/jen303.
19. Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014(63):2438–88.
20. Gillmore, JD, Maurer, MS, Falk, RH, Merlini, G, Damy, T, Dispenzieri, A, Wechalekar, AD, Berk, JL, Quarta, CC, Grogan, M, et al. Nonbiopsy diagnosis of cardiac Transthyretin Amyloidosis. Circulation 133 (2016), 2404–2412 PubMed PMID: 27143678 10.1161/CIRCULATIONAHA.116.021612.
21. Schelbert, EB, Piehler, KM, Zareba, KM, Moon, JC, Ugander, M, Messroghli, DR, Valeti, US, Chang, CC, Shroff, SG, Diez, J, et al. Myocardial fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the Spectrum of ejection fraction and heart failure stage. J Am Heart Assoc, 4(12), 2015 10.1161/JAHA.115.002613.
22. Feingold, B, Salgado, CM, Reyes-Mugica, M, Drant, SE, Miller, SA, Kennedy, M, Kellman, P, Schelbert, EB, Wong, TC, Diffuse myocardial fibrosis among healthy pediatric heart transplant recipients: correlation of histology, cardiovascular magnetic resonance, and clinical phenotype. Pediatr Transplant, 21(5), 2017 10.1111/petr.12986.
23. Cornwell, GG 3rd, Murdoch, WL, Kyle, RA, Westermark, P, Pitkanen, P, Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation. Am J Med 75 (1983), 618–623.
24. Phelan, D, Collier, P, Thavendiranathan, P, Popovic, ZB, Hanna, M, Plana, JC, Marwick, TH, Thomas, JD, Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis. Heart 98 (2012), 1442–1448 PubMed PMID: 22865865 10.1136/heartjnl-2012-302353.
25. Bokhari, S, Castano, A, Pozniakoff, T, Deslisle, S, Latif, F, Maurer MS: (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. Circ Cardiovasc Imaging 6 (2013), 195–201 PubMed PMID: 23400849; PMCID 3727049 10.1161/CIRCIMAGING.112.000132.
26. Gillmore, JD, Maurer, MS, Falk, RH, Merlini, G, Damy, T, Dispenzieri, A, Wechalekar, AD, Berk, JL, Quarta, CC, Grogan, M, et al. Non-biopsy diagnosis of cardiac Transthyretin Amyloidosis. Circulation 133:24 (2016), 2404–2412.
27. Longhi, S, Guidalotti, PL, Quarta, CC, Gagliardi, C, Milandri, A, Lorenzini, M, Potena, L, Leone, O, Bartolomei, I, Pastorelli, F, et al. Identification of TTR-related subclinical amyloidosis with 99mTc-DPD scintigraphy. JACC Cardiovasc Imaging 7 (2014), 531–532 PubMed PMID: 24831216 10.1016/j.jcmg.2014.03.004.
28. Treibel, TA, Bandula, S, Fontana, M, White, SK, Gilbertson, JA, Herrey, AS, Gillmore, JD, Punwani, S, Hawkins, PN, Taylor, SA, Moon, JC, Extracellular volume quantification by dynamic equilibrium cardiac computed tomography in cardiac amyloidosis. J Cardiovasc Comput Tomogr 9 (2015), 585–592 PubMed PMID: 26209459; PMCID 4684159 10.1016/j.jcct.2015.07.001.
29. Banypersad, SM, Fontana, M, Maestrini, V, Sado, DM, Captur, G, Petrie, A, Piechnik, SK, Whelan, CJ, Herrey, AS, Gillmore, JD, et al. T1 mapping and survival in systemic light-chain amyloidosis. Eur Heart J 36 (2015), 244–251 PubMed PMID: 25411195 10.1093/eurheartj/ehu444.
30. Fontana, M, Banypersad, SM, Treibel, TA, Abdel-Gadir, A, Maestrini, V, Lane, T, Gilbertson, JA, Hutt, DF, Lachmann, HJ, Whelan, CJ, et al. Differential Myocyte responses in patients with cardiac Transthyretin Amyloidosis and light-chain Amyloidosis: a cardiac MR imaging study. Radiology 277 (2015), 388–397 PubMed PMID: 25997029 10.1148/radiol.2015141744.
31. Schelbert, EB, Testa, SM, Meier, CG, Ceyrolles, WJ, Levenson, JE, Blair, AJ, Kellman, P, Jones, BL, Ludwig, DR, Schwartzman, D, et al. Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson, 13, 2011, 16 PubMed PMID: 21375743; PMCID 3059279 10.1186/1532-429X-13-16.
32. Hawkins, PN, Ando, Y, Dispenzeri, A, Gonzalez-Duarte, A, Adams, D, Suhr, OB, Evolving landscape in the management of transthyretin amyloidosis. Ann Med 47 (2015), 625–638 PubMed PMID: 26611723; PMCID 4720049 10.3109/07853890.2015.1068949.
33. Castano, A, Narotsky, DL, Hamid, N, Khalique, OK, Morgenstern, R, DeLuca, A, Rubin, J, Chiuzan, C, Nazif, T, Vahl, T, et al. Unveiling transthyretin cardiac amyloidosis and its predictors among elderly patients with severe aortic stenosis undergoing transcatheter aortic valve replacement. Eur Heart J 38 (2017), 2879–2887 PubMed PMID: 29019612 10.1093/eurheartj/ehx350.
34. Karamitsos, TD, Piechnik, SK, Banypersad, SM, Fontana, M, Ntusi, NB, Ferreira, VM, Whelan, CJ, Myerson, SG, Robson, MD, Hawkins, PN, et al. Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis. JACC Cardiovasc Imaging 6 (2013), 488–497 PubMed PMID: 23498672 10.1016/j.jcmg.2012.11.013.
35. Fontana, M, Banypersad, SM, Treibel, TA, Maestrini, V, Sado, DM, White, SK, Pica, S, Castelletti, S, Piechnik, SK, Robson, MD, et al. Native T1 mapping in transthyretin amyloidosis. JACC Cardiovasc Imaging 7 (2014), 157–165 PubMed PMID: 24412190 10.1016/j.jcmg.2013.10.008.
36. Dweck, MR, Boon, NA, Newby, DE, Calcific aortic stenosis: a disease of the valve and the myocardium. J Am Coll Cardiol 60 (2012), 1854–1863 PubMed PMID: 23062541 10.1016/j.jacc.2012.02.093.